Teva abandons Ajovy trial for cluster headaches

24th April 2019 Uncategorised 0

A Phase III study found that the primary endpoint for weekly average number of cluster headache attacks during the four-week treatment period is unlikely to be met.

More: Teva abandons Ajovy trial for cluster headaches
Source: News